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Axonal outgrowth is associated with increased
ERK 1/2 activation but decreased caspase 3
linked cell death in Schwann cells after
immediate nerve repair in rats
Yoshifumi Tsuda1,3, Martin Kanje2, Lars B Dahlin3*
Abstract
Background: Extracellular-signal regulated kinase (ERK1/2) is activated by nerve damage and its activation
precedes survival and proliferation of Schwann cells. In contrast, activation of caspase 3, a cysteine protease, is
considered as a marker for apoptosis in Schwann cells. In the present study, axonal outgrowth, activation of ERK1/2
by phosphorylation (p-ERK 1/2 ) and immunoreactivity of cleaved caspase 3 were examined after immediate,
delayed, or no repair of transected rat sciatic nerves.
Results: Axonal outgrowth, detected by neurofilament staining, was longer after immediate repair than after either
the delayed or no repair conditions. Immediate repair also showed a higher expression of p-ERK 1/2 and a lower
number of cleaved caspase 3 stained Schwann cells than after delayed nerve repair. If the transected nerve was
not repaired a lower level of p-ERK 1/2 was found than in either the immediate or delayed repair conditions.
Axonal outgrowth correlated to p-ERK 1/2, but not clearly with cleaved caspase 3. Contact with regenerating axons
affected Schwann cells with respect to p-ERK 1/2 and cleaved caspase 3 after immediate nerve repair only.
Conclusion: The decreased regenerative capacity that has historically been observed after delayed nerve repair
may be related to impaired activation of Schwann cells and increased Schwann cell death. Outgrowing axons
influence ERK 1/2 activation and apoptosis of Schwann cells.
Background
Delayed repair of a peripheral nerve trunk after injury
often results in impaired axonal regeneration and poor
clinical outcome, although this depends on the duration
of the delay [1-3]. Schwann cells are rapidly activated
after a nerve injury and start to dedifferentiate and pro-
liferate [4,5]. Insufficient nerve regeneration after
delayed nerve repair has been attributed to an inability
of Schwann cells to support axonal outgrowth [6]. To
achieve a good clinical outcome after nerve repair it is
important to clarify the molecular mechanisms by which
Schwann cell proliferation and apoptosis are orche-
strated. A few studies have focused on signal transduc-
tion mechanisms with respect to axonal outgrowth after
immediate and delayed nerve repair. However, signal
transduction has sparsely been investigated after nerve
injuries with and without accompanying repair. For
instance, the activation of Extracellular signal-Regulated
Kinase (ERK1/2) and the induction of apoptosis in
Schwann cells have been observed after a nerve injury
and after a long delayed nerve repair, respectively [7,8].
In this study, we examined activation of ERK1/2 and
induction of cleaved caspase 3 in Schwann cells after
immediate, delayed or no repair of transected rat sciatic




p-ERK 1/2 stained Schwann cells were observed both at
the site of the lesion (SNL) and in the distal nerve seg-
ment (SND) with a higher intensity in all experimental
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groups than in the uninjured control nerve (Figure 1A).
There were significant differences among the groups at
the site of the lesion (ANOVA, p < 0.001, Figure 1B)
and in the distal nerve segment (ANOVA; p < 0.01;
Figure 1B). Immunopositive area for p-ERK1/2 was
higher at the site of the lesion compared to the corre-
sponding distal nerve segment when immediate repair
(group I; Student’s t-test; p < 0.01) and no delayed
nerve repair (i.e. group DN; Student’s t-test; p < 0.05)
was performed, but not after a delayed nerve repair (D;
Student’s t-test; p = 0.36) and when no repair (evalua-
tion at 7 days; i.e. group N; Student’s t-test; p = 0.06;
Figure 1) was done. A large immunopositive area for
p-ERK1/2 was observed in the group with immediate
nerve repair both at the site of the lesion and in the dis-
tal nerve segment, where the p-ERK1/2 positive area at
the site of the lesion was almost twice as large as
observed in the delayed repair group (Fisher’s PLSD p <
0.001; Figure 1B). In the distal nerve segment, there
were no significant differences between the groups of
immediate and delayed nerve repair (Fisher’s PLSD p =
0.06; Figure 1B). The immunopositive area was lower,
however, when no immediate nerve repair (i.e. group N)
was done than after immediate nerve repair at the two
measured sites (Fisher’s PLSD; SNL p < 0.001 and SND
p < 0.001; Figure 1B). The corresponding values in the
experiments where a delayed or no delayed repair was
done were p = 0.11 for SNL and p = 0.06 for SND. No
differences were found between the experiments where
no nerve repairs were done (SNL p = 0.88; SND p =
0.99), where the analyses of p-ERK 1/2 were done 7
(i.e. group N) and 21 (i.e. group DN) days after injury.
There were no differences between the four groups in
the contralateral uninjured nerves with respect to p-
ERK1/2. Double staining with ERK1/2 and S-100
revealed that all cells with an elongated nucleus and
located within the basal lamina (our definition of
Schwann cell [1]) also stained for S-100, indicating that
all our selection criteria were correct, and they also
stained for p-ERK1/2 (in accordance with our previous
report [7,8]).
Cleaved caspase 3
Cells containing cleaved caspase 3 could be identified
as Schwann cells based on their shape and location [8]
(Figure 1A). Double staining with cleaved caspase 3
and S-100 confirmed this identification (Figure 2).
There were significant differences between the groups
at the site of the lesion (SNL; ANOVA, p < 0.05) and
in the distal nerve segment (SND; ANOVA p < 0.001)
(Figure 1C). The number of cleaved caspase 3 stained
cells was higher at the site of the lesion compared to
further down in the corresponding distal nerve seg-
ment (SND) in all groups (group I p < 0.01; group N p
< 0.01; group DN p < 0.05), except when a delayed
nerve repair was done (group D; p = 0.06, Figure 1C).
The numbers of cleaved caspase 3 stained cells were
significantly increased in the group with a delayed
nerve repair compared to those in the group with
immediate nerve repair both at the site of the lesion
(Fisher’s PLSD p < 0.05) and in the distal nerve seg-
ment (p < 0.001; Figure 1C). The numbers of cells
were not different at the two sites in the corresponding
experiments where no nerve repairs were done of the
transected nerve trunk compared to the nerve repair
groups (SNL evaluated at 7 and 21 days p = 0.25 and
p = 0.62, respectively; SND p = 0.98 and p = 0.89,
respectively). Furthermore, when comparing the experi-
ments where no nerve repairs were done and analyzed
after 7 and 21 days (i.e. groups N and DN), no differ-
ence in caspase 3 stained cells were detected at the site
of the lesion (p = 0.093), but was almost twice as high
at 21 days in the distal nerve segment (SND p < 0.001;
Figure 1C). There were no significant differences
between the four groups in the contralateral uninjured
nerves.
Length of axonal outgrowth
Axonal outgrowth from the proximal nerve segment into
the corresponding distal nerve segments after nerve
repair or from the proximal nerve segment after no
repair was evaluated at 7 days post surgery by neurofila-
ment staining (Figure 3) and was found to be different
among the groups (ANOVA; p < 0.001; Figure 3). In the
groups where no repair was done most of the proximal
stumps of the sciatic nerve formed a neuroma and with
axonal outgrowth of only a few mm (significantly shorter
than when repair was done; Fisher’s PLSD; p < 0.001 and
< 0.001). Axonal outgrowth after immediate nerve repair
was longer than in any of the other groups; thus longer
than after delayed nerve repair (p < 0.05; Figure 3).
Correlations
The length of axonal outgrowth correlated to the
expression of p-ERK 1/2 (whole material including no
repairs) both at the site of the lesion (SNL; p < 0.001, r2
= 0.59) and in the distal nerve segment (SND; p <
0.001, r2 = 0.55), while the length did not correlate with
numbers of caspase 3 stained cells (whole material; SNL;
p = 0.14 and SND p = 0.85; Figure 4). However, if only
the repaired groups were included for cleaved caspase 3,
the corresponding values were p = 0.04, r2 = 0.43 (SNL)
and p = 0.08 (SND).
Discussion
Activation of p-ERK1/2 and cleaved caspase 3 in
Schwann cells was different after immediate and delayed
nerve repair in the rat sciatic nerve and axonal
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Figure 1 Results of immunocytochemical staining for ERK1/2 and cleaved caspase 3 analyzed in the distal nerve segment after
immediate, delayed and no nerve repairs. Immunocytochemical staining for p-ERK1/2 (A) in longitudinal sections at the site of the lesion
(a)-(d) [(a) group I (immediate repair), (b) group N (no repair), (c) group D (delayed repair), (d) group DN (delayed no repair)], and in the distal
nerve segment (e)-(h) [(e) group I, (f) group N, (g) group D, (h) group DN]. Contralateral uninjured nerve is shown in (i). The scale bar represents
100 μm. The graphs show the percentages of immunopositive area for p-ERK1/2 (B) expressed as mean + SD. The stars indicate p-values * <
0.05: ** < 0.01; *** < 0.001. Immunocytochemical staining for cleaved caspase 3 (A) in longitudinal sections at the site of the lesion (j)-(m) [(j)
group I, (k) group N, (l) group D, (m) group DN], and in the corresponding distal nerve segment (n)-(q) [(n) group I, (o) group N, (p) group D,
(q) group DN]. Contralateral uninjured nerve is shown in (r). The scale bar represents 100 μm. The graphs in (B) show the number of the caspase
3 positive cells per 0.01 mm2 expressed as mean + SD. The stars indicate p-values * < 0.05: ** < 0.01; *** < 0.001.
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outgrowth was longer after immediate repair. In addi-
tion, the length of axonal outgrowth correlated with
ERK 1/2 activation, but not clearly correlated with
cleaved caspase 3 stained cells. Thus, even a short delay
of nerve repair as 14 days results in impaired axonal
outgrowth. The mitogen activating pathway kinase
(MAPK) ERK1/2 is one important signaling pathway
and activation of ERK 1/2 (p-ERK1/2) promotes
Schwann cell proliferation after nerve injury [7,9-15].
Schwann cells are removed by apoptosis during develop-
ment before myelination and during regeneration after
nerve injury [16,17], which can be marked by caspase 3
or by TUNEL staining [8,18-20]. Nick labelling of apop-
totic nuclei of sensory neurons [21] after injury has also
been detected.
The immunopositive area for evaluation of p-ERK1/2
was present more predominantly at the site of the
nerve lesion after immediate nerve repair, where 3[H]-
thymidine incorporation is maximal after a nerve injury
[22,23]. The increased presence of p-ERK1/2 at site of
lesion after immediate repair could be related to
contact between Schwann cells and regenerating axons
[24] and to a cellular response similar as suggested for
STAT-3 in the distal nerve segment far from site of
lesion [15]. Notably, a recent report indicates that
functional recovery of injured nerves does not require
Schwann cell proliferation [16]. However, in the con-
tralateral nerve ERK 1/2 is low in the presence of unin-
jured axons, indicating that the nature of axonal
contact is important. The positive correlation between
length of axonal outgrowth and p-ERK1/2 stained area
is reasonable since activation of ERK 1/2 is required
for Schwann cell proliferation and that axonal out-
growth positively correlates to number of Schwann
cells; thus, consistent with that Schwann cell prolifera-
tion is crucial for nerve regeneration [10,24].
The decreased p-ERK1/2 immunopositive area after a
delayed nerve repair suggests that the responsiveness of
Schwann cells is weaker already after a 14 days delayed
nerve repair; further supported by findings of no differ-
ences between site of lesion and distal nerve segment
with respect to ERK 1/2 and cleaved caspase 3 after
delayed nerve repair. Activation of ERK 1/2 was still
observed after 21 days, which is consistent with a pre-
vious report observing ERK 1/2 16 days after nerve
transection [15]. The present experimental design with a
delayed nerve repair included two injuries to the nerve
with a 14 day interval. Such a conditioning lesion, i.e.
first injury, can improve axonal outgrowth after a sec-
ond lesion [25]. However, conditioning by transection
[26] has a lower effect on axonal outgrowth than that of
a conditioning crush lesion [23].
Of the counted total number of cells stained by DAPI
in the contralateral uninjured nerve, more than 90% had
an elongated nucleus and were located inside the basal
lamina (criteria of Schwann cells; results not shown).
The corresponding numbers at site of lesion and in dis-
tal nerve segment were 70 and 85%, indicating that
most cells were Schwann cells. In addition, double stain-
ing of Schwann cells with cleaved caspase 3 and S-100
also showed that most of the cleaved caspase 3 stained
cells were Schwann cells.
The number of cleaved caspase 3 stained cells was sig-
nificantly higher after a delayed nerve repair in accor-
dance with a previous study using longer time points
before repair [8]. A higher number of cleaved caspase 3
stained cells after a delayed nerve repair may contribute
to impaired axonal outgrowth, since the extent of out-
growth is dependent on the number of Schwann cells
[22]. A longer delay than 14 days severely impairs axonal
outgrowth and correlates to expression of the transduc-
tion factor ATF 3 and inversely to number of cleaved
caspase 3 stained Schwann cells [1,8]. Taken together
with present findings, it strongly suggests that a prompt
nerve repair should be performed after a nerve injury.
Figure 2 Double staining with S-100 and cleaved caspase 3 in
a control nerve (A) and in a repaired (B) sciatic nerve from the
distal nerve segment. The staining indicated that cleaved caspase
3 stained cell nuclei (green) was associated with S-100 staining
(red). DAPI-stained cells (blue) were used to localize cell nuclei.
Length of bars 50 μm (A) and 25 μm (B).
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The neurobiological data support the clinical observation
that a delayed nerve repair following transection or
laceration may impair functional recovery [2,3].
Conclusion
A decreased regenerative capacity after a delayed nerve
repair is associated with an impaired activation of
Schwann cells and an increased death of Schwann cells
(apoptosis). The regenerating axons influence the ERK




Twenty Wistar female rats (Mollegaard; Denmark), with
a body weight of about 200g, were used for the experi-
ments. Experiments were conducted in accordance with
international standards on animal welfare and compliant
with local and national regulations and were approved
by the Animal Ethical Committee of Lund University.
The rats were anesthetized with an intraperitoneal injec-
tion of a mixture of pentobarbital sodium (60 mg/ml,
Apoteksbolaget, Stockholm, Sweden) and sodium chlor-
ide in 1:10 volume proportions. Adequate measures
were taken to minimize pain and discomfort. After the
rats were anesthetized, the left sciatic nerve was exposed
at midthigh level and transected where after the follow-
ing procedures were done.
Four different groups were made to study the influ-
ence of delayed or no nerve repair (Figure 5A). In
group I (immediate repair), the nerve was immediately
repaired after transection by epineurial sutures using
9-0 nylon (n = 5). In group N (non-repair), the nerve
was not repaired after transection (n = 5; control to
group I with the same follow up time). In group D
(delayed repair), the transected nerve was left untreated
for 14 days and then repaired (n = 5) with only a slight
trimming of the proximal and distal nerve ends to pro-
vide clean nerve ends for the repair. In group DN
(delayed non-repair), the transected nerve was left
untreated with no repair (n = 5; control of group D
with the same follow up time; Figure 5A). The wounds
were closed after transection and repair and the rats
were allowed to recover.
Seven days after the surgery (i.e. 7 days after surgical
procedure in group I and N and 21 days after the nerve
transection in group D and DN; Figure 5A), the rats
were killed by an intraperitoneal injection of an over-
dose of sodium pentobarbital followed by a heart punc-
ture. Both sciatic nerves of each animal were removed
Figure 3 Length of regenerating axons in the distal nerve segment. Axonal outgrowth was evaluated by measuring the length
of stained neurofilaments, and the graph shows the length of the neurofilaments (mm) expressed as mean + SD. The stars indicate
p-values * < 0.05: *** < 0.001.
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and applied on paper with appropriate stretching. The
samples were fixed in Stefanini’s fixative (4% parafor-
maldehyde and 1.9% picric acid in 0.1M phosphate buf-
fer, pH 7.2) for two hours. They were washed in 0.01 M
PBS (phosphate buffered saline, pH7.4) and kept in 20%
sucrose in 0.01 M PBS until processing.
The sciatic nerve pieces were embedded in O.C.T
Compound (Sakura Finetek Europe, Leidens, Nether-
lands) and rapidly frozen in a freezer. The samples were
longitudinally sectioned in a cryostat at 10-μm thick-
ness, mounted on to Super Frost® plus slides (Menzel-
Glaser, Germany), and kept in -80° C until processing.
Immunohistochemistry
p-ERK 1/2
The sections were air dried, washed in PBS for 5 min,
and thereafter incubated with a primary rabbit-anti-p-
ERK1/2 antibody (9101, Cell Signaling technology, USA)
at a dilution of 1:500 in 0.25% Triton-X-100 (Sigma-
Aldrich,USA) and 0.25% bovine serum albumin (BSA;
Sigma-Aldrich,USA) in PBS overnight at 4° C. The sec-
tions were then washed three times (5 min per wash)
and incubated with the secondary Alexa flour 488 goat-
anti-rabbit antibody (Molecular Probes, Eugene, Oregon,
USA) at a dilution of 1:500 in 0.25% Triton-X-100 and
0.25% BSA in PBS for 1 hour at room temperature. All
sections were mounted after washing and the nuclei
were counterstained with DAPI.
Cleaved caspase 3
Other sections from the same specimen were incubated
with cleaved caspase 3 antibody (Invitro Sweden AB,
Stockholm, Sweden) at a dilution of 1:200 in 0.25% Triton-
X-100 and 0.25% bovine serum albumin in PBS overnight
at 4° C. After rinsing three times in PBS (5 min per rinse),
the sections were incubated with the secondary Alexa
flour 488 goat-anti-rabbit antibody at a dilution of 1:500 in
0.25% Triton-X-100 and 0.25% BSA in PBS for 1 hour at
room temperature. All sections were mounted after wash-
ing and the nuclei were counterstained with DAPI.
Neurofilaments
To measure the length of regenerating axon, additional
sections from the same specimens were stained with a
monoclonal mouse anti-neurofilament antibody (Dako
Cytomation, Glostrup, Denmark), which was diluted at
1:80 in 0.25% Triton-X-100 and 0.25% BSA in PBS, for
2 hours at 4° C. After three 5 minute rinses in PBS,
Alexa Fluor 594 goat-anti-mouse IgG at a dilution of
1:500 (Molecular Probes, Eugene, Oregon, USA) in
0.25% Triton-X-100 and 0.25% BSA in PBS was used as
the secondary antibody for 1 hour at room temperature.
Double staining with S-100
To confirm localization of cleaved caspase 3 within
Schwann cells, the sections were double stained with the
antibody to cleaved caspase 3 (1:200; 9661, Cell Signal-
ing Technology, USA) in 0.25% bovine serum albumin
(BSA) and 0.25% Triton X-100 in PBS at 4° overnight.
After additional rinse in PBS three times (5 min each),
the sections were incubated with anti-rabbit Alexa Fluor
(488; 1:500; Invitrogen AB Lidingö, Sweden) for 1h at
room temperature. After incubation and wash three
times (5 min each) with PBS, the sections were incu-
bated with anti S-100 antibody (a/b chain, sc 58839,
Santa Cruz; 1:300) in 0.25% BSA and 0.25% Triton X-
100 in PBS at 4° overnight. The sections were then
washed three times (5 min each) and incubated with
Rhodamin-conjugated goat IgG fraction to mouse IgG
(Cappel™ MP Biomedicals, LLC,Ohio; 1:500) for 1h in
room temperature. Finally, the sections were washed
three times (5 min each) in PBS and mounted with 4’,
6-diamino-2-phenylindole (DAPI) Vectashield® mount-
ing medium for fluorescence (Vector Laboratories, Inc.
Burlingame, CA 94010).
Photography and image analysis
The sections were photographed using a fluorescence
microscope (Eclipse, Nikon, Tokyo, Japan) equipped
with a digital camera system (Digital sight DF-U1,
Nikon, Tokyo, Japan). p-ERK 1/2 and cleaved caspase 3
immunoreactivity were subjected to image analysis
(Figure 5B) at two different locations in the distal nerve
segment [a) at the site of the lesion (SNL) and b) at a
site 15 mm distal to the site of the lesion (SND)] and in
one segment from the contralateral uninjured nerve
according to the procedure previously described by
Saito and Dahlin [1]. The analyses were done in three
randomly selected sections from each specimen.
For the p-ERK1/2 analysis, the sections were con-
verted to 8-bit grey scale TIFF using Adobe Photoshop
7.0 (Adobe, San Jose, California, USA) and then
imported into ImageJ 1.37 (a public domain image ana-
lysis program developed at the US National Institutes of
Figure 4 Graphs of regression analyses between length of
neurofilaments (mm, dependent) and p-ERK 1/2 and cleaved
caspase 3 (independent) at site of lesion and in distal nerve
segment. For p-values and r2 see Results.
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Health and available at http://rsb.info.nih.gov./nih-
image). In ImageJ, the tool density slice was used
to determine the immunostained area of the nerve
piece on images, which was captured at 4 × objective
magnification. The immunopositive area was expressed
as percentage of the total endoneurial area of the speci-
fic area in the section at the site of the lesion (SNL), in
the distal nerve segment (SND) and in the contralateral
uninjured nerve. The imageJ program was used to mea-
sure the intensity of p-ERK1/2. A region of interest (100
Figure 5 Schematic drawing showing (A) the experimental design with immediate (I), delayed (D) and no nerve repairs (N and DN)
and (B) the sites where p-ERK 1/2 and cleaved caspase 3 were analyzed.
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× 100 pixels) was selected in the endoneurial area furth-
est away from the transection site to estimate the immu-
nofluorescent intensity of the background ± 3SD
(standard deviations). The intensity was then measured
on the immunostained area and expressed as percentage
of the total area of the nerve section [7].
For the cleaved caspase 3 analyses, the total number of
caspase 3 stained Schwann cells in four randomly selected
areas (each area 100 × 100 μm) were counted and the
mean number of Schwann cells was used for analysis.
The length of the neurofilament-stained regenerating
axons was measured in the microscope and expressed in
millimeters [1].
Statistical methods
Obtained values are expressed as mean (+SD; Figure 1
and 3). Analysis of variance (ANOVA) with subsequent
post hoc Fisher’s PLSD was used to test for significant
differences between appropriate groups. A Student’s
t-test (unpaired) was used to detect any difference
between SNL and SND values in each group. A p-value
of less than 0.05 was regarded as significant. A simple
regression was used to test for correlation between
length of axonal outgrowth and the other variables. The
analyses were done by the software StatView program.
Acknowledgements
The authors have no conflicts of interest. This work is supported by grants
from the Swedish Research Council (Medicine and Natural Science), Konsul
Thure Carlsson Fund for Medical Research, Region Skåne and Funds from
the University Hospital Malmö, Sweden. We thank Lena Stenberg for help
with some staining procedures.
Author details
1Department of Orthopedic Surgery, National Defense Medical College,
Saitama, Japan. 2Department of Cell and Organism Biology, Lund University,
Lund, Sweden. 3Department of Clinical Sciences Malmö - Hand Surgery,
Lund University, Malmö Sweden.
Authors’ contributions
All authors have contributed to the formation of the manuscript in different
ways; in design of the study (YT, MK, LD), in surgery and
immunohistochemical analyses (YT); in statistics (LD), in interpretation of the
data (YT, MK, LD) and in the creation of the manuscript (YT, MK, LD). All
authors have read and approved the final manuscript.
Received: 8 April 2010 Accepted: 21 January 2011
Published: 21 January 2011
References
1. Saito H, Dahlin LB: Expression of ATF3 and axonal outgrowth are
impaired after delayed nerve repair. BMC Neurosci 2008, 9:88.
2. Jivan S, Kumar N, Wiberg M, Kay S: The influence of pre-surgical delay on
functional outcome after reconstruction of brachial plexus injuries. J
Plast Reconstr Aesthet Surg 2009, 62:472-479.
3. Ruijs AC, Jaquet JB, Kalmijn S, Giele H, Hovius SE: Median and ulnar nerve
injuries: a meta-analysis of predictors of motor and sensory recovery
after modern microsurgical nerve repair. Plast Reconstr Surg 2005,
116:484-494, discussion 495-486.
4. Chen ZL, Yu WM, Strickland S: Peripheral regeneration. Annu Rev Neurosci
2007, 30:209-233.
5. Stoll G, Muller HW: Nerve injury, axonal degeneration and neural
regeneration: basic insights. Brain Pathol 1999, 9:313-325.
6. Sulaiman OA, Gordon T: Role of chronic Schwann cell denervation in
poor functional recovery after nerve injuries and experimental strategies
to combat it. Neurosurgery 2009, 65:105-114.
7. Martensson L, Gustavsson P, Dahlin LB, Kanje M: Activation of extracellular-
signal-regulated kinase-1/2 precedes and is required for injury-induced
Schwann cell proliferation. Neuroreport 2007, 18:957-961.
8. Saito H, Kanje M, Dahlin LB: Delayed nerve repair increases number of
caspase 3 stained Schwann cells. Neurosci Lett 2009, 456:30-33.
9. Akassoglou K, Yu WM, Akpinar P, Strickland S: Fibrin inhibits peripheral
nerve remyelination by regulating Schwann cell differentiation. Neuron
2002, 33:861-875.
10. Triolo D, Dina G, Lorenzetti I, Malaguti M, Morana P, Del Carro U, Comi G,
Messing A, Quattrini A, Previtali SC: Loss of glial fibrillary acidic protein
(GFAP) impairs Schwann cell proliferation and delays nerve regeneration
after damage. J Cell Sci 2006, 119:3981-3993.
11. Agthong S, Kaewsema A, Tanomsridejchai N, Chentanez V: Activation of
MAPK ERK in peripheral nerve after injury. BMC Neurosci 2006, 7:45.
12. Harrisingh MC, Perez-Nadales E, Parkinson DB, Malcolm DS, Mudge AW,
Lloyd AC: The Ras/Raf/ERK signalling pathway drives Schwann cell
dedifferentiation. EMBO J 2004, 23:3061-3071.
13. Wiklund P, Ekstrom PA, Edstrom A: Mitogen-activated protein kinase
inhibition reveals differences in signalling pathways activated by
neurotrophin-3 and other growth-stimulating conditions of adult mouse
dorsal root ganglia neurons. J Neurosci Res 2002, 67:62-68.
14. Liu RY, Snider WD: Different signaling pathways mediate regenerative
versus developmental sensory axon growth. J Neurosci 2001, 21:RC164.
15. Sheu JY, Kulhanek DJ, Eckenstein FP: Differential patterns of ERK and
STAT3 phosphorylation after sciatic nerve transection in the rat. Exp
Neurol 2000, 166:392-402.
16. Yang DP, Zhang DP, Mak KS, Bonder DE, Pomeroy SL, Kim HA: Schwann
cell proliferation during Wallerian degeneration is not necessary for
regeneration and remyelination of the peripheral nerves: axon-
dependent removal of newly generated Schwann cells by apoptosis. Mol
Cell Neurosci 2008, 38:80-88.
17. Nakao J, Shinoda J, Nakai Y, Murase S, Uyemura K: Apoptosis regulates the
number of Schwann cells at the premyelinating stage. J Neurochem 1997,
68:1853-1862.
18. Iida H, Schmeichel AM, Wang Y, Schmelzer JD, Low PA: Schwann cell is a
target in ischemia-reperfusion injury to peripheral nerve. Muscle Nerve
2004, 30:761-766.
19. Gupta R, Steward O: Chronic nerve compression induces concurrent
apoptosis and proliferation of Schwann cells. J Comp Neurol 2003,
461:174-186.
20. Krajewska M, Wang HG, Krajewski S, Zapata JM, Shabaik A, Gascoyne R,
Reed JC: Immunohistochemical analysis of in vivo patterns of expression
of CPP32 (Caspase-3), a cell death protease. Cancer Res 1997,
57:1605-1613.
21. Ekström PA: Neurones and glial cells of the mouse sciatic nerve undergo
apoptosis after injury in vivo and in vitro. Neuroreport 1995, 6:1029-1032.
22. Sjöberg J, Kanje M, Edström A: Influence of non-neuronal cells on
regeneration of the rat sciatic nerve. Brain Res 1988, 453:221-226.
23. Sjoberg J, Kanje M: Effects of repetitive conditioning crush lesions on
regeneration of the rat sciatic nerve. Brain Res 1990, 530:167-169.
24. Yamazaki T, Sabit H, Oya T, Ishii Y, Hamashima T, Tokunaga A, Ishizawa S,
Jie S, Kurashige Y, Matsushima T, et al: Activation of MAP kinases, Akt and
PDGF receptors in injured peripheral nerves. J Peripher Nerv Syst 2009,
14:165-176.
25. Sjöberg J, Kanje M: The initial period of peripheral nerve regeneration
and the importance of the local environment for the conditioning
effect. Brain Res 1990, 529:79-84.
26. Kerns JM, Danielsen N, Holmquist B, Kanje M, Lundborg G: The influence of
predegeneration on regeneration through peripheral nerve grafts in the
rat. Exp Neurol 1993, 122:28-36.
doi:10.1186/1471-2202-12-12
Cite this article as: Tsuda et al.: Axonal outgrowth is associated with
increased ERK 1/2 activation but decreased caspase 3 linked cell death
in Schwann cells after immediate nerve repair in rats. BMC Neuroscience
2011 12:12.
Tsuda et al. BMC Neuroscience 2011, 12:12
http://www.biomedcentral.com/1471-2202/12/12
Page 8 of 8
